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A series of new inhibitors for cysteine proteinases with the general structure Z-Phe-Gly-NHO-CO-Aa (Aa = amino acids) was synthesized and tested 
as inhibitors of papain-like enzymes (cathepsins S, L, B and papain). Like N-peptidyl-O-acyl hydroxamates the inhibitors inactivate cysteine 
proteinases by a sulfenamidation of the active site cysteine residue. The most effective inhibitors display second order-rate constants of inactivation 
in the range of lo’-lo4 M-‘Y’. Since the structure of the N-peptidyl-O-carbamoyl amino acid hydroxamates allows the variation of the leaving 
group this class of inhibitors was used as a new tool for the evaluation of the S,’ specificity of cysteine proteinases. 
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1. INTRODUCTION 
N-Peptidyl-0-acyl hydroxamates are known as spe- 
cific and potent inactivators of cysteine proteinases [l- 
31. The variability of their N-acyl and 0-acyl portions 
opens the opportunity to regulate effectively the affinity 
and reactivity towards the enzymes. The aliphatic and 
aromatic 0-acyl residues tested so far were mainly used 
to control the reactivity of the leaving group by elec- 
tronic effects. However, the introduction of an amino 
acid or peptide in the leaving group should allow the 
study of the S’ specificity of proteases. 
Up to the present moment little is known about the 
S’ specificity of cysteine proteinases. Two recently pub- 
lished papers deal with the Si specificity of papain using 
two different approaches: 
(i) peptide nucleophiles as deacylating agents [4] and 
(ii) intramolecularly quenched fluorogenic peptide sub- 
strates which allow variations of P’ amino acid residues 
[5]. Both approaches elect alanine as the the most effec- 
tive residue in P,’ from a range of hydrophobic and 
non-hydrophobic residues. However, whereas the 
acylenzyme binds more efficiently hydrophobic bulky 
amino residues [4], the hydrolysis of peptide substrates 
is decreased with increasing hydrophobicity in the P,’ 
position [5]. 
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These apparently conflicting results may be caused by 
different rate-determining steps. 
In the present paper we report the inactivation of 
cysteine proteinases of the papain superfamily with sev- 
eral N-peptidyl-0-carbamoyl amino acid hydroxamates 
and compare the SZ’ specificity of these proteases. 
2. MATERIALS AND METHODS 
2.1. Enzymes 
Cathepsin L (EC 3.4.22.15) and cathepsin B (EC 3.4.22.1) were 
prepared from the lysosomal fraction of rat liver [6,7]. Cathepsin S 
(EC 3.4.22.27) was isolated from bovine spleen as previously described 
[8]. Papain (EC 3.4.22.2) was purchased from Serva, Heidelberg, Ger- 
many. 
2.2. Substrates and inhibitors 
Z-Phe-Arg-MCA and Z-Val-Val-Arg-MCA were synthesized as de- 
scribed in [9]. Z-Phe-Gly-NHOH was synthesized as previously re- 
ported [2]. The hydroxamic acid was transformed into a N-peptidyl- 
O-4nitrophenylformate hydroxamate (Z-Phe-Gly-NHO-CO-ONPh) 
with 4nitrophenyl chloroformate in dry tetrahydrofuran. The N-pep- 
tidyl04nitrophenylformate hydroxamate was finally coupled with 
a sodium salt of an amino acid suspension in dimethylformamide. 
Homogeneity and integrity of the newly synthesized compounds 
were established by TLC, NMR, elemental analysis and mass spec- 
troscopy (Z-Phe-Gly-NHO-NBz: Anal. Calcd. for &H1408N4: C, 
58.98; H, 4.65; N, 10.77. Found: C, 58.81; H, 4,58; N, 10.67; Mass 
Calcd. 520.16. Found: 520.1; Z-FG-NHO-CO-Phe: Anal.Cald. for 
C29H,,0sN,: C, 61.90; H, 5.38; N, 9.96. Found: C, 61.80; H, 5.32; N, 
9.92; Mass Calcd. 562.21. Found: 562.1; Z-Phe-Gly-NHO-CO-Leu: 
Anal. Calcd. for C26H3208N4: C, 59.07, H, 6.11, N, 10.60. Found: C, 
59.23; H, 5,89; N, 10.55; Mass Calcd. 528.22. Found: 5?8.1; Z-Phe- 
Gly-NHO-CO-Val: Anal. Calcd. for &H,,O,N,: C, 58.34; H, 5.88; 
N, 10.89. Found: C, 587.24; H, 5.71; N, 10.59; Mass Calcd. 514.21. 
Found: 514.2; Z-Phe-Gly-NHO-CO-Ala: Anal. Calcd. for 
CZ,H,,OsN,: C, 56.77; H, 5.39; N, 11.52. Found: C, 56.84; H, 5.46; N, 
11.48; Mass Calcd. 486.17. Found: 486.2; Z-Phe-Gly-NHO-CO-Gly: 
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Anal. Calcd. for CZzHz408N,: C, 55.91; H, 5.12; N, 11.89. Found: C, 
55.93; H, 5.13; N, 11.89. Mass Calcd. 472.16. Found: 472.1). 
2.3. Enzyme assays 
The inactivation of cysteine proteinases with substrate-analogous 
inhibitors proceeds according to Equation 1: 
E + I 2 E-1 :E-I (1) 
k-1 
where EI, E-I, k,, k-, represent he enzyme-inhibitor complex, the 
inactivated enzyme, and the rate constants of the non-covalent 
Michaelis-Menten complex. k, is the rate constant of the irreversible 
inactivation of the enzyme. 
The inactivation rates (kobs) in presence of substrate and for differ- 
ent inhibitor concentrations were determined for the cysteine pro- 
teinases according to Tian and Tsou [lo]. By fitting the rate constants 
for different inhibitor concentrations to the Michaelis-Menten plot, 
the second-order ate constants kJKTPP were obtained. The k2/KFPP- 
values were corrected to zero substrate concentration using Equation 
2. 
k,lK, = k,lK,“PP x (1 + [S]/K,,,) (2) 
The progress curves for the inactivation of the cysteine proteinases in 
the presence of MCA-substrates were monitored at 22°C with a 
Shimadzu spectrophotometer UV-300 equipped with a fluorescence- 
detection unit at an excitation wavelength of 383 nm and with an 
emission filter of 450 nm. 
The kinetic experiments were performed with a constant enzyme 
concentration (cathepsin L: 0.7 nM, cathepsin S: 2.0 nM, cathepsin 
B: 0.9 nM, papain: 3.1 nM) in 50 mM sodium acetate buffer (pH 5.5) 
for cathepsin L; in 50 mM potassium phoshate buffer (pH 6.5) for 
cathepsin S; in 50 mM potassium phosphate buffer (pH 6.0) for 
cathepsin B and in 50 mM Tris-HCl buffer (pH 7.5) for papain. The 
cathepsins L and B (stored in their Hg-inhibited form) were activated 
in the assay buffers containing 2.5 mM dithioerythreitol, and 2.5 mM 
EDTA x Na, for 5 min at 25”C, whereas cathepsin was preincubated 
for 15 min in its assay buffer containing 5 mM dithioerythreitol, 5mM 
EDTA x Na, and 0.01% Triton X-100. 
Substrates used were Z-Phe-Arg-MCA (1 PM for cathepsin L, K,,, 
2.8 PM [9], 50pM for cathepsin B, K,,, 250pM [9], 10 PM for papain, 
K,,, 50 PM (unpublished, D. Bromme)) and Z-Val-Val-Arg-MCA (10 
PM for cathepsin S, K, 17 PM A). 
2.4. Mass spectroscopy 
For the determination of the molecular mass of free papain and the 
papain-inhibitor adduct a triple quadrupole mass spectrometer (API 
III LC/MS system, Sciex, Thornhill, Ontario, Canada) was used as 
described in [ll]. The molecular mass was calculated from the m/z 
peaks in the charge distribution profiles of the multiply charged ions 
[12]. Samples for mass spectrometric analysis were prepared in a buffer 
free mixture of papain (40pM) and inhibitor (Z-FG-NHO-CO-Phe 40 
PM and 400 PM) in 10% acetonitrile. The formation of an inactive 
enzyme-inhibitor adduct was followed by measuring the residual ac- 
tivity. 
3. RESULTS AND DISCUSSION 
N-peptidyl-O-carbamoyl amino acid hydroxamates 
are irreversible inhibitors of cysteine proteinases. They 
belong to the class of N-O-diacyl hydroxamates, which 
are known as very potent inhibitors of lysosomal cyste- 
ine proteinases [1,2]. The inactivation of the enzyme 
follows a sulfenamidation of the active-site cysteine res- 
idue [13] as shown by mass spectroscopy (Fig. 1). The 
molecular mass obtained for the free enzyme was 
212 
23,422 + 0.6 (calculated from the amino acid sequence: 
23,422 Da) and for the papain-inhibitor adduct 
23,774 * 2.6 (calculated: 23,776 Da). The same type of 
enzyme-inhibitor adduct was already shown for the in- 
activation of papain with the Z-FG-NHO-CO- 
(2,4,6Me,)Ph [13]. 
The second order rate constants of the tested inhib- 
itors with an amino acid in the P,’ position are l-2 
orders of magnitude lower than for the nitrobenzyl 
compound (compound 1). This is related to the weaker 
electronic withdrawing effect of the amino acids as leav- 
ing groups. 
N-peptidyl-O-carbamoyl amino acid hydroxamates 
allow an extension of the leaving group with amino 
acids and thus the study of the S’ specificity of cysteine 
b 
Fig. 1. Partial mass spectra of papain: (a) in presence of the inhibitor 
Z-Phe-Gly-NHO-CO-Phe (molar inhibitor-enzyme ratio = 1) and (b) 
in presence of the inhibitor Z-Phe-Gly-NHO-CO-Phe (molar inhibi- 
tor-enzyme ratio = 20). Peak a corresponds to the free enzyme (23,422 
Da) and peak b to the sulfenamide (23,776 Da). The other minor peaks 
correspond to sodium and sulfate adducts of papain as reported in 
t131. 
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proteinases. Since the hydroxylamine carbonyl-moiety 
mimics a glycine residue (-NH-O-CO-) in P,’ position, 
the subsequent amino acids should interact with the S,’ 
subsite. 
The data in Table I show that alterations in the P,’ 
position of the inhibitor effect the second-order-rate 
constants of inactivation. The most effective inhibitor 
for the cathepsins L and S and for papain is compound 
2 with a phenylalanine in P,‘. Glycine (compound 6) in 
this position diminishes the inactivation constants by a 
factor of lo-30 for these enzymes. Fig. 2 clearly illus- 
trates that with increasing hydrophobicity of the P,‘- 
residue the potential of the inhibitor increases too. Only 
cathepsin B is characterized by a different specificity. In 
general it displays a weaker discrimination between the 
tested P,’ residues and it prefers rather non-aromatic 
amino acid residues such as leucine and valine than 
phenylalanine and shows no detectable time-dependent 
inhibition with the glycine derivative. This may be re- 
lated to the very different S’ binding site in cathepsin B 
when compared with the other proteinases of the papain 
superfamily. The S’ binding site in cathepsin B is closed 
by the so-called occluding loop, which explains the pep- 
tidyldipeptidase activity of the enzyme [14]. 
The decrease in the second-order ate constants par- 
allel to the decrease of hydrophobicity of the leaving 
group of the inhibitors for papain and the cathepsins S 
and L is mainly due to an increase in pi:,. This reveals 
that especially the binding of the inhibitor is influenced 
by hydrophobicity of the P,’ residue. The S; specificity 
of the cathepsins S and L and papain is consistent with 
recently published results for papain using peptide sub- 
strates [S] and peptide nucleophiles [4]. In the case of 
1 
15 
Papain Cathepsin S Cathepsin L Cathepsin B 
Fig. 2. Comparison of k,/K, values of the inactivation of papain and 
the cathepsins S, L and B by Z-Phe-Gly-NHO-CO-Aa (Aa: F = Phe, 
L = Leu, V = Val, A = Ala, G = Gly). The values are normalized to 
I for Z-Phe-Gly-NHO-CO-Phe. 
substrates the k,,,lK, values decrease with increased 
hydrophibicity of the P,’ residue. Here mainly the kc,, 
value is affected indicating the influence on the acyla- 
tion rate. The authors [5] argued that increased hydro- 
phobic interactions between the P,’ and S2’ papain bind- 
ing site retard the release of the C-terminal product. On 
the other hand, the deacylation rate of papain was en- 
hanced by using peptide nucleophiles with increased 
hydrophobicity in the putative P,’ position [4]. 
The effect of hydrophobic interactions between the 
ligand and the enzyme depends on the mechanism and 
the catalytic step which is affected and can therefore be 
Inactivation 
Table I 
of the cysteine proteinases cathepsin S, cathepsin L, cathepsin B and papain with N-peptidyl-O-carbamoyl amino acid hydroxamates 
(Z-Phe-Gly-NHO-CO-Aa) 
Aa k2 (s-l) lo3 
Cathepsin S 
4 W) k,lK 
(M-’ .s-‘) 
kz (s-l) 10’ 
Cathepsin L 
4 OtM) 
1 4-NO,Ph 86f 1 0.9 f 0.03 95,600 41*4 0.044 f 0.004 931,800 
2 Phe 2.1 f 0.1 0.25 f. 0.05 8,400 13.0 f 1 0.19 * 0.04 68,420 
3 Leu 4.7 t 0.4 1.01 f 0.2 4,650 8.2 * 0.8 0.42 ? 0.08 19,520 
4 Val _ 710” 4.0 * 0.1 0.71 * 0.1 5,630 
5 Ala 2.7 ? 0.2 7.5 f 1.3 360 6.1 + 0.3 0.97 + 0.08 6,290 







Cathepsin B Papain 
190 * 30 12 & 2 15,800 76+ 13 15 * 5 5,070 
5.0 f 0.4 6.7 f 1.1 750 27.0 + 4 25 ? 4 1,080 
4.8 f 0.4 4.1 f 0.6 1,170 9.7 f 0.6 19 f 2 510 
1.1 * 0.05 1 .o f 0.2 1,100 3.0 f 1.0 20 f 3 150 
2.4 ? 0.2 6.4 f 1.7 375 5.6 f 0.2 18f2 310 
3b 5.6 f 0.2 57 f 8 98 
“No saturation kinetics achieved 
b Competitive inhibition 
213 
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of opposite character. This can be exploited in the de- 
sign of inhibitors and substrates. Inhibitors of papain 
and the cathepsins S and L demand bulky hydrophobic 
residues in Pz’, whereas substrates should contain 
smaller residue in this position. 
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